GeneCopoeia OncoSpot Cancer Cell Lines

Friday, 01 June, 2018 | Supplied by: United Bioresearch Products Pty Ltd


Cancer cell lines

GeneCopoeia offers premade cancer cell lines carrying diverse gene mutations commonly seen in tumour biomarkers, including EGFR, KRAS and BRAF in the MAPK pathway.

The mutant cells are engineered based on the HCT116 cancer cell line, in which mutations are integrated either homozygously or heterozygously using CRISPR technology. They can be used to enhance our understanding of cancer biology and the development of cancer therapies, either as cell line models for the study of metabolic and signalling pathways or as in vitro models for drug screening and toxicity studies.

The cell lines feature puromycin resistance for easy growth and maintenance. Mutations are available in both homozygous and heterozygous forms. Premade cell lines are available for next-day shipping; a custom cell line service is also available.

For more information: http://www.genecopoeia.com/product/cell-biology-product/cancer-mutant-cell-lines/.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

AdipoGen Life Sciences APRIL ELISA Kit and BAFF ELISA Kit

AdipoGen Life Sciences has released ELISA kits for the specific quantitative determination of the...

Cayman Chemical Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit

Cayman Chemical's Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit is a cell-based...

Thermo Fisher Scientific Applied Biosystems PureQuant Assays

Applied Biosystems PureQuant Assays, from Thermo Fisher Scientific, are a family of assays that...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd